Search

everythinglearnresearchcommunity

for

Search:↓

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

Spironolactone is a safe and effective treatment for reducing excessive hair growth in women.

Hair loss increases with age; alcohol raises risk, more female partners lowers it.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

Finasteride can cause lasting sexual, emotional, and cognitive issues, with varying severity.

New treatments for male hypogonadism are effective and should be personalized.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Finasteride effectively treats male hair loss, improving growth and density.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

Both genetic and lifestyle factors significantly affect female hair loss.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

The document concludes that more research is needed to fully understand the causes of PCOS.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Acne and increased body hair in teenage girls are normal but severe cases may need hormone evaluation and treatment can prevent diabetes linked to PCO.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.